Pierre Pujol
AeroLeads people directory · profile

Pierre Pujol Email & Phone Number

Pharma/Biotech executive, consultant at Trilo Therapeutics
Location: Redwood City, California, United States 8 work roles 3 schools
1 work email found @thecenter.nasdaq.org 2 phones found area 650 LinkedIn matched
4 data sources Profile completeness 100%

Contact Signals · 1 work email · 2 phones

Work email p****@thecenter.nasdaq.org
Direct phone (650) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Pharma/Biotech executive, consultant
Location
Redwood City, California, United States

Who is Pierre Pujol? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Pierre Pujol is listed as Pharma/Biotech executive, consultant at Trilo Therapeutics, based in Redwood City, California, United States. AeroLeads shows a work email signal at thecenter.nasdaq.org, phone signal with area code 650, and a matched LinkedIn profile for Pierre Pujol.

Pierre Pujol previously worked as Chief Business Officer at Trilo Therapeutics and Co-founder and Advisory Board member at Airlib Inc. Pierre Pujol holds Mba - Additionally Admitted To The Harvard Mba Program from Insead.

Company email context

Email format at Trilo Therapeutics

This section adds company-level context without repeating Pierre Pujol's masked contact details.

{first}.{last}@thecenter.nasdaq.org
86% confidence

AeroLeads found 1 current-domain work email signal for Pierre Pujol. Compare company email patterns before reaching out.

Profile bio

About Pierre Pujol

Global professional with a track record of successfully developing businesses and mobilizing high-quality teams in the pharma/biotech/cleantech industries. High energy and thoughtful executive who delivered strong results across several businesses and geographies, including the US, Europe and China. I have been passionate about life sciences my entire life and have tried to leverage my interest into meaningful societal impacts throughout my career, from contributing to increasing the animal protein supply in China, to bringing to market new and better medicines, and to fighting industrial pollution. Along this journey, my analytical and people skills brought me to the business side of these scientific endeavors. While I quickly climbed the corporate ladder in large organizations, I also enjoyed my involvement in bold and daring startups. I successfully contributed to the corporate strategy and commercialization activities in two Pharma companies (GSK, Sanofi), to the business development and operational management of several biotech companies (Chiron, Maxygen and Eos) and to the emergence of several start-ups, including Oakbio, Airlib and Trilo Therapeutics, two of which I co-founded.Key skills:- Holistic understanding of the drug R&D / product decision-making process and commercialization.- Complement great scientific teams with commercial /financial insights for efficient decision-making.- Engage effectively cross-functionally at all levels of the organization, from bench to Board. - Excellent analytical skills, qualitative and quantitative, ideal for strategy and product/deal valuations.- Selected to join the elite GSK executive development program and trained by BCG consulting for 1 year.- P&L management, change and transformation, and organization efficiency, including streamlining.- Bridge across cultural gaps for efficient communication (lived /worked in France, China, the UK and the USA).Corporate Strategy, Corporate Development, Clinical trials, Product Management, Drug Development, Strategic Planning, Valuation, Project Management, Management Consulting, Business Process Improvement, Forecasting, Modelling, Marketing, Data Analysis, Business Analysis, Finance, Net Present Value, Team Leadership, Executive Management, International Business, Due-diligence, Microsoft Office, PowerPoint, Excel, P&L management, streamlining organization, organizational efficiency, change and transformation.

Listed skills include Start Ups, Business Development, Venture Capital, Strategy, and 19 others.

Current workplace

Pierre Pujol's current company

Company context helps verify the profile and gives searchers a useful next step.

Trilo Therapeutics
Trilo Therapeutics
Pharma/Biotech executive, consultant
AeroLeads page
8 roles · 29 years

Pierre Pujol work experience

A career timeline built from the work history available for this profile.

Chief Business Officer

Current

San Francisco, California, US

  • A novel discovery platform of fully synthetic macrocyclic peptidomimetics for ADC drug development.
  • Co-led the technology platform positioning, drug target selection and business model.
  • Generated interest from potential pharma collaborators and negotiated the first R&D agreement.
  • Co-led budgeting and milestones setting, developed promotional materials and funding outreach.
Jan 2022 - Present

Co-Founder And Advisory Board Member

Current

Scottsdale, Arizona, US

  • IOT solution to produce interactive high-resolution traffic pollution maps to reduce in-cabin exposure.
  • Developed the value proposition, go-to-market strategy and recruited key Advisory Board members.
  • Identified and developed business partnerships with Big Data firms and OEM car manufacturers.
Sep 2016 - Present

Chief Executive Officer

Oakbio Inc. (Now Novonutrients Inc.)
  • Fighting Climate Change: A novel bioprocess for industrial emissions (CO2) capture and recycling.
  • Co-authored and managed grants from CA Energy Commission, CCEMC, Canada and the EU (SMEs).
  • Sourced and managed collaborations with Shell Petroleum, Lafarge SA, Heidelberg AG and PG&E.
  • Created a Carbon Life Cycle Assessment model for our technology validated by PWC.
  • Managed 15 employees, sourced and negotiated a strategic partnership with access to $15M in funding.
Sep 2009 - Aug 2016

Senior Consultant

Principal at PartnerVision Ventures: Hi-Tech incubator which creates, patents and Seed fund. Think tank of the founder of iAtlas and Hotels.com. Reviewed 50+ investment opportunities, wrote the business plan for VoIP TalkPlus, which raised $5.5M Series A.Co-Founder and CBO at Emiliem Inc. / Elara Biosciences: a spin-off from Eos Therapeutics developing a.

2001 - Aug 2009

Vp, Corporate Business Development

Sunnyvale, California, US

  • Developed the first strategic plan and portfolio review process. Oversaw all M&A and BD activities. Set up commercialization structure and product-gating process. Prepared all business materials for the Board of.
  • Acting President of vaccines business unit with 40 employees, $12M P&L. Negotiated deals with IAVI ($3.6MM), DARPA ($12MM) and Aventis (undisclosed).
Oct 2000 - Jul 2001

Head, Global Portfolio Analysis Group (Group Vp Level)

Glaxo Welcome Plc. ( Now Gsk)
  • Head and co-Chair, Global Portfolio Analysis Group (Group VP level)
  • Designed the “Go/No-Go” product review process at the end of Phase II and Phase III Clinical Trials.
  • Co-Chaired the review of 7 products, representing a future investment of more than $3B.
  • Moderated cross-functional teams (Clinical Development, Finance, Manufacturing, Regulatory Affairs and US/EU markets), with independent reviews of inputs to identify key value drivers.
  • Facilitated the resolution of outstanding issues and prepared final recommendation reports for the Executive Committee decisions.Leader of a Management Consulting team in a Global Commercialization Task Force (Sr..
  • A company's wide organizational development effort aimed at improving clinical products' selection and market launch success.
1997 - 2000 ~3 yrs

Director, Strategic Planning And Business Development

Emeryville, California, US

  • Led a cross-functional team to develop the vaccines’ unit first-ever strategic plan, developed a consolidated financial model integrating a major acquisition (Biocine-Sclavo), developed the first product pipeline.
  • Performed valuation studies for patents and products in-licensing and M&A, led due-diligence process and was part of the team making valuations during negotiations of acquisition by Ciba-Geigy (Novartis).
May 1994 - Sep 1995
3 education records

Pierre Pujol education

Mba - Additionally Admitted To The Harvard Mba Program

Insead

Msc & Engineering + 3 Years Towards Phd Macroeconomics

Agroparistech

Bsc. (Deug), Biology

Université Paul Sabatier Toulouse Iii
FAQ

Frequently asked questions about Pierre Pujol

Quick answers generated from the profile data available on this page.

What company does Pierre Pujol work for?

Pierre Pujol works for Trilo Therapeutics.

What is Pierre Pujol's role at Trilo Therapeutics?

Pierre Pujol is listed as Pharma/Biotech executive, consultant at Trilo Therapeutics.

What is Pierre Pujol's email address?

AeroLeads has found 1 work email signal at @thecenter.nasdaq.org for Pierre Pujol at Trilo Therapeutics.

What is Pierre Pujol's phone number?

AeroLeads has found 2 phone signal(s) with area code 650 for Pierre Pujol at Trilo Therapeutics.

Where is Pierre Pujol based?

Pierre Pujol is based in Redwood City, California, United States while working with Trilo Therapeutics.

What companies has Pierre Pujol worked for?

Pierre Pujol has worked for Trilo Therapeutics, Airlib Inc, Nasdaq Entrepreneurial Center, Oakbio Inc. (Now Novonutrients Inc.), and Startups.

How can I contact Pierre Pujol?

You can use AeroLeads to view verified contact signals for Pierre Pujol at Trilo Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did Pierre Pujol attend?

Pierre Pujol holds Mba - Additionally Admitted To The Harvard Mba Program from Insead.

What skills is Pierre Pujol known for?

Pierre Pujol is listed with skills including Start Ups, Business Development, Venture Capital, Strategy, Business Strategy, Biotechnology, Entrepreneurship, and Cross Functional Team Leadership.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.